MAC-1-Sp3

General Information


DRACP ID  DRACP06011

Peptide Name   MAC-1-Sp3

Sequence  GFGⓍALKⓍLKKVL

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Stapled Peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Chymotrypsin hydrolysis

Affinity  Not available

Mechanism  Resisting chymotrypsin hydrolysis

Nature  Anticancer; Antimicrobial; Anti-hemolysis



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic (Stapled)

Disulfide/Other Bond  Stapled: Ⓧ(4) and Ⓧ (8) are cross-linked by hydrocarbon stapling

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  Ⓧ=(2R)-2-amino-2-methyl-6-heptenoic acid

Chiral  L



Physicochemical Information


Formula  C57H96N14O10

Absent amino acids  CDEHIMNPQRSTWY

Common amino acids  KL

Mass  135171

Pl  11.1

Basic residues  3

Acidic residues  0

Hydrophobic residues  6

Net charge  3

Boman Index  882

Hydrophobicity  59.23

Aliphatic Index  120

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN113896766A

Patent Title  Novel anti-tumor cyclic peptide active molecule, preparation method and application

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.